Metabolic syndrome and rare gynecological cancers in the Metabolic syndrome and Cancer project (Me-Can)

Annals of Oncology

Volumn 22, Issue 6, 2011, Pages 1339-1345

  Nagel, G ^a   Concin, H ^b   Bjorge T ^c,d   Rapp, K ^a   Manjer, J ^e   Hallmans, G ^f   Diem, G ^b   Haggstrom C ^g   Engeland, A ^c,d   Almquist, M ^e   Jonsson, H ^g   Selmer, R ^d   Stocks, T ^g   Tretli, S ^h   Ulmer, H ⁱ   Stattin, P ^g   Lukanova, A ^j  

^a UNIVERSITY OF ULM   (Germany)

^b AGENCY FOR PREVENTIVE AND SOCIAL MEDICINE   (Austria)

^c UNIVERSITY OF BERGEN   (Norway)

^d NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^e LUND UNIVERSITY HOSPITAL   (Sweden)

^f Nutritional Research   (Sweden)

^g UMEÅ UNIVERSITY   (Sweden)

^h CANCER REGISTRY OF NORWAY   (Norway)

ⁱ INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^j GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

more..

Author keywords

Epidemiology; MetS; Rare gynecological cancers

Indexed keywords

CHOLESTEROL; GLUCOSE; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; FEMALE; GLUCOSE BLOOD LEVEL; GYNECOLOGIC CANCER; HUMAN; MAJOR CLINICAL STUDY; META ANALYSIS; METABOLIC SYNDROME X; OBESITY; PRIORITY JOURNAL; RISK FACTOR; TRIACYLGLYCEROL BLOOD LEVEL; VAGINA CANCER; VULVA TUMOR;

EID: 79957849240     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdq597     Document Type: Article

References (32)

1. Parkin DM, Whelan SL, Ferlay J. et al. Cancer Incidence in Five Continents. Lyon, France: IARC 2002.
2. Bodelon C, Madeleine MM, Voigt LF, Weiss NS. Is the incidence of invasive vulvar cancer increasing in the United States? Cancer Causes Control 2009; 20(9): 1779-1782.
3. Duarte-Franco E, Franco EL. Other Gynecologic Cancers: endometrial, ovarian, vulvar and vaginal cancers. BMC Womens Health 2004; 4 (Suppl 1): S14.
4. Madeleine MM, Daling JR. Cancers of the vulva and vagina. In Schottenfeld D, Fraumeni, JF (eds), Cancer Epidemiology and Prevention, 3rd edition. New York: Oxford University Press 2006; 1068-1074.
5. Brinton LA, Nasca PC, Mallin K. et al. Case-control study of cancer of the vulva. Obstet Gynecol 1990; 75(5): 859-866.
6. Brinton LA, Nasca PC, Mallin K. et al. Case-control study of in situ and invasive carcinoma of the vagina. Gynecol Oncol 1990; 38(1): 49-54.
7. Madsen BS, Jensen HL, van den Brule AJ. et al. Risk factors for invasive squamous cell carcinoma of the vulva and vagina-population-based casecontrol study in Denmark. Int J Cancer 2008; 122(12): 2827-2834.
8. Bjorge T, Dillner J, Anttila T. et al. Prospective seroepidemiological study of role of human papillomavirus in non-cervical anogenital cancers. BMJ 1997; 315(7109): 646-649.
9. Munoz N, Kjaer SK, Sigurdsson K. et al. Impact of human papillomavirus (HPV)-6/ 11/16/18 vaccine on all HPV-associated genital diseases in young women. J Natl Cancer Inst 2010; 102(5): 325-339.
10. Madeleine MM, Daling JR, Carter JJ. et al. Cofactors with human papillomavirus in a population-based study of vulvar cancer. J Natl Cancer Inst 1997; 89(20): 1516-1523.
11. Smith JS, Backes DM, Hoots BE. et al. Human papillomavirus type-distribution in vulvar and vaginal cancers and their associated precursors. Obstet Gynecol 2009; 113(4): 917-924.
12. Parazzini F, La Vecchia C, Garsia S. et al. Determinants of invasive vulvar cancer risk: an Italian case-control study. Gynecol Oncol 1993; 48(1): 50-55.
13. Sherman KJ, Daling JR, McKnight B, Chu J. Hormonal factors in vulvar cancer. A case-control study. J Reprod Med 1994; 39(11): 857-861.
14. O'Mara BA, Byers T, Schoenfeld E. Diabetes mellitus and cancer risk: a multisite case-control study. J Chronic Dis 1985; 38(5): 435-441.
15. Stocks T, Borena W, Strohmaier S. et al. Cohort profile: the Metabolic syndrome and Cancer project (Me-Can). Int J Epidemiol 2010; 39(3): 660-667.
16. Bjorge T, Stocks T, Lukanova A. et al. Metabolic syndrome and endometrial carcinoma. Am J Epidemiol 2010; 171(8): 892-902.
17. World Health Organisation. Obesity: preventing and managing the global epidemic. Report of a WHO consultation on obesity. Geneva, Switzerland: WHO 1998.
18. Clarke R, Shipley M, Lewington S. et al. Underestimation of risk associations due to regression dilution in long-term follow-up of prospective studies. Am J Epidemiol 1999; 150(4): 341-353.
19. Wood AM, White I, Thompson SG. et al. Regression dilution methods for meta-analysis: assessing long-term variability in plasma fibrinogen among 27,247 adults in 15 prospective studies. Int J Epidemiol 2006; 35(6): 1570-1578.
20. Stocks T, Rapp K, Bjorge T. et al. Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts. PLoS Med 2009; 6(12): e1000201.
21. Wood AM, White IR, Thompson SG. et al. Correcting for multivariate measurement error by regression calibration in meta-analyses of epidemiological studies. Stat Med 2009; 28(7): 1067-1092.
22. Barlow L, Westergren K, Holmberg L, Talback M. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 2009; 48(1): 27-33.
23. Rapp K, Schroeder J, Klenk J. et al. Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia 2006; 49(5): 945-952.
24. Larsen IK, Smastuen M, Johannesen TB. et al. Data quality at the Cancer Registry of Norway: an overview of comparability, completeness, validity and timeliness. Eur J Cancer 2009; 45(7): 1218-1231.
25. Parazzini F, Moroni S, Negri E. et al. Selected food intake and risk of vulvar cancer. Cancer 1995; 76(11): 2291-2296.
26. Daling JR, Madeleine MM, Schwartz SM. et al. A population-based study of squamous cell vaginal cancer: HPV and cofactors. Gynecol Oncol 2002; 84(2): 263-270.
27. Maruthur NM, Bolen SD, Brancati FL, Clark JM. The association of obesity and cervical cancer screening: a systematic review and meta-analysis. Obesity (Silver Spring) 2009; 17(2): 375-381.
28. Khovidhunkit W, Kim MS, Memon RA. et al. Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host. J Lipid Res 2004; 45(7): 1169-1196.
29. Newcomb PA, Weiss NS, Daling JR. Incidence of vulvar carcinoma in relation to menstrual, reproductive, and medical factors. J Natl Cancer Inst 1984; 73(2): 391-396.
30. Gardner H, Kaufman R. Benign Diseases of the Vulva and Vagina. Boston, MA: GK Hall 1981.
31. Calle EE, Thun MJ. Obesity and cancer. Oncogene 2004; 23(38): 6365-6378.
32. Ager EI, Neo J, Christophi C. The renin-angiotensin system and malignancy. Carcinogenesis 2008; 29(9): 1675-1684.